Leadership

Institutions bring value to industry not only through shared coursework or customized training programs, but also through leveraging the intellectual property of institutional personnel for corporate problem solving.

World-class talent seeks its own level, so hiring companies should make sure that those involved in the interviewing process are strong employees who represent the company as leaders in their own rights.

For the third year in a row, Abbott Labs has made it into the top 10 companies judged by DiversityInc magazine to have the most diverse workforce. According to DiversityInc co-founder Luke Visconti, that makes Abbott, number five in the ranking, extraordinary. Merck is the only other pharma company to make the cut, but comes in at number 24, and is on a downturn-it was ranked 13 last year.

You can have a biotech company with a great technology base, but if it doesn't have a product in Phase II development, Wall Street won't reward the company by increasing the value of its stock price. When products are valued over technology, there is a higher premium for commercially-focused business leaders.

MVPs go beyond numbers to create extraordinary value for companies and their stockholders. They are the top two to five percent of employees. In other words, if you were to lose 100 people, which two to five would you protect at all costs?

The time is ripe to further a pharmaceutical career in the United States. The industry is full of promising opportunities for people eager to contribute and advance.

CEOs are expected to be visionaries who set a bold direction for their organizations and inspire people to greatness. But leaders at other levels of the organization must also master the art of stirring up enthusiasm within their groups if they are to reach their common goals.

The word diversity is prevalent in human resources (HR) vocabulary. Companies have established offices of diversity, heightened awareness about it, and opened a dialogue about the issues of workplace heterogeneity. Yet, the results of those efforts are often hard to find in the hallways of corporate America. Although some women are likely to be seen around the conference tables, people of color are conspicuously missing.

A legion of prospective career-oriented reps stands at the gates, waiting to join the ranks of the pharmaceutical industry.

Progress for women has always been on the agenda for the Healthcare Businesswomen}s Association. Founded in 1979, with almost 100 members, HBA is now more than 1,000 members strong. To support its commitment to the advancement of women in the healthcare industry, HBA has tracked key issues affecting women}s career development since 1997.